Please login to the form below

Not currently logged in
Email:
Password:

Havas’ UK Nurofen campaign to cost £3m

Reckitt Benckiser rolls out TV advertisements in time for flu and cold season
Nurofen campaign

Havas has created a new TV campaign to promote Reckitt Benckiser's painkiller Nurofen in time for flu and cold season.

The campaign for Nurofen was launched on October 28 and will appear on prime time and key daytime TV across a range of terrestrial and other stations.

Part of a £3m promotional campaign, the ad will support the full New Nurofen Cold and Flu Adult range with an emphasis on the Nurofen Cold & Flu Relief GSL line.

The ad, which continues with the brand's 'Lives bigger than pain' theme, is expected to reach more than 85 per cent of the UK's adult population. It will underline how the Nurofen Cold & Flu range can help people carry on through the winter months without winter ailments taking charge.

The TV campaign will be supported by other activity including underground promotion and social media activity. Havas, the agency behind the ad, was also responsible for last winter's Nurofen TV campaign, which marked the brand's launch into the cold and flu category.

Available in more than 40 countries, Nurofen is the fastest growing analgesic brand globally and the leading analgesic brand in UK, Australia and New Zealand, according to owner Reckitt Benckiser.

Article by
Tara Craig

31st October 2013

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics